medigraphic.com
ISSN 1608-8921 (Print)

2020, Number 1

Next >>

Gaceta Médica Espirituana 2020; 22 (1)

Covid-19. Neurological manifestations

García ZJ, Pérez RM, Bender BJE

Language: Spanish
References: 12
Page: 1-6
PDF size: 256.68 Kb.


Text Extraction

Coronaviruses were known for many years for causing frequent respiratory and digestive diseases; but of slight intensity in immunocompetent people. At the beginning of this century, in 2002 and 2012, new strains of this family originated the severe acute respiratory syndrome (SARS-CoV) and the respiratory syndrome of the Middle East (MERS-CoV) respectively, both are considered emerging diseases from an animal reservoir, and responsible for severe respiratory infections of epidemic nature with great international repercussion due to its high morbidity and mortality.
In December 2019, in Wuhan, China, a group of 27 patients with pneumonia of unknown etiology was reported; soon after, Chinese researchers identified a new type of coronavirus as the causative agent, later called SARS-CoV-2. The disease was called covid-19 (coronavirus disease 2019). Due to its unstoppable expansion and high lethality, on March 11 the World Health Organization (WHO) declared it as a global pandemic.
SARS-CoV-2 is considered to affect the upper and lower respiratory tracts simultaneously, thus, it justifies its known transmission power and the basis for its most recognized respiratory symptoms, including pneumonia, which may or may not cause respiratory failure. To this “common or typical clinical picture” are added the clinical manifestations that reflect the involvement of other organs or systems, including the nervous system, those become more valuable as knowledge of the disease deepens.


REFERENCES

  1. Paules CI, Marston HD, Fauci AS. Coronavirus Infections—More Than Just the Common Cold. JAMA[Internet]. 2020[cited 2020 April 11];323(8):707-8. Disponible en: https://jamanetwork.com/journals/jama/fullarticle/2759815?appid=scweb

  2. Lu R, Zhao X, Li J, Niu P, Yang B, Wu H, et al. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet[Internet]. 2020[cited 2020 April 11];395(10224): 565‐74. Disponible en: https://www.sciencedirect.com/science/article/pii/S0140673620302518

  3. Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet[Internet]. 2020 [cited 2020 April 11];395(10223):497-506. Disponible en: https://www.sciencedirect.com/science/article/pii/S0140673620301835?via%3Dihub

  4. Morfopoulou S, Brown JR, Davies EG, Anderson G, Virasami A, Qasim W, et al. Human Coronavirus OC43 Associated with Fatal Encephalitis. N Engl J Med 2016. [cited 2020 April 11];375(5):497-8. Disponible en: https://www.nejm.org/doi/pdf/10.1056/NEJMc1509458?articleTools=true

  5. Mao L, Wang M, Chen S, He Q, Chang J, Hong C, et al. Neurological Manifestations of Hospitalized Patients with covid-19 in Wuhan, China: a retrospective case series study. medRxiv [Internet]. 1 de enero de 2020. [cited 2020 April 11];preprint arxiv. Disponible en: https://www.medrxiv.org/content/10.1101/2020.02.22.20026500v1.full.pdf+html DOI: 10.1101/2020.02.22.20026500.

  6. Wang HY, Li XL, Yan ZR, Sun XP, Han J, Zhang BW. Potential neurological symptoms of COVID-19. Ther Adv Neurol Disord[Internet]. 2020 Mar 28[cited 2020 April 11];(13). Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7119227/pdf/10.1177_1756286420917830.pdf DOI: 10.1177/1756286420917830

  7. Zhao H, Shen D, Zhou H, Liu J, Chen S. Guillain-Barré syndrome associated with SARS-CoV-2 infection: causality or coincidence? Lancet Neurol[Internet]. 2020 [Published Apr 1, 2020 cited 2020 Apr 11];19(5):369-470. Disponible en: https://www.thelancet.com/action/showPdf?pii=S1474-4422%2820%2930109-5 DOI: https://doi.org10.1016/S1474-4422

  8. Baig AM, Khaleeq A, Ali U, Syeda H. Evidence of the COVID-19 Virus Targeting the CNS: Tissue Distribution, Host–Virus Interaction, and Proposed Neurotropic Mechanisms. ACS chemical neuroscience[Internet]. 2020 [Published online 2020 Mar 13; cited 2020 Apr 11];11(7): 995-8. Disponible en: https://pubs.acs.org/doi/pdf/10.1021/acschemneuro.0c00122 DOI: 10.1021/acschemneuro.0c00122

  9. Poyiadji N, Shahin G, Noujaim D, Stone M, Patel S, Griffith B. COVID-19–associated Acute Hemorrhagic Necrotizing Encephalopathy: CT and MRI Features. Radiology[Internet]. 2020 [Published online 31 Mar 2020; cited 2020 April 11] Disponible en: https://doi.org/10.1148/radiol.2020201187

  10. Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, et al. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus–Infected Pneumonia in Wuhan, China. JAMA[Internet]. 2020 [Published online 17 Mar 2020; cited 2020 April 11];323(11):1061-69. Disponible en: https://jamanetwork.com/journals/jama/fullarticle/2761044 DOI: 10.1001/jama.2020.1585

  11. Li Y‐C, Bai W‐Z, Hashikawa T. The neuroinvasive potential of SARS‐CoV2 may play a role in the respiratory failure of COVID‐19 patients. J Med Virol[Internet]. 2020; [First published: 27 Feb 2020;cited 2020 April 11];92(6):552-5. Disponible en: https://onlinelibrary.wiley.com/doi/epdf/10.1002/jmv.25728 DOI: https://doi.org/10.1002/jmv.25728

  12. León-Castellón R, Bender-del-Busto J, Velázquez-Pérez L. Afectación del sistema nervioso por la COVID-19. Anales de la Academia de Ciencias de Cuba [Internet]. [citado 2020 abr 19];10(2):[aprox. 0 p.]. Disponible en: http://www.revistaccuba.cu/index.php/revacc/article/view/760/796




2020     |     www.medigraphic.com